Approval · Notice of Compliance 4504 · 1996
PROBETA: Notice of Compliance 4504
Issued February 2, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4504
- Date
- February 2, 1996
- Company
- Allergan IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Glaucoma therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROBETA | 02209071 | Cancelled Post Market |
Medicinal ingredients
- DIPIVEFRIN HYDROCHLORIDE 0.1 PER
- LEVOBUNOLOL HCL 0.5 PER